|
|
|
|
|
by kaczordon
1596 days ago
|
|
What this study does show is that with a booster shot you are offered significant immunity against COVID, including omicron.
The confidence interval is between 10%-60% for the booster, oddly selective of you to pick the highest number. The FDA standard is to have at least 50% VE, with lower bound CI >30% for EUA. What this study does show is that immunity is trending down and will likely hit 0 within a few months once the antibody response wanes. So yes, omicron does spread easily which is the original point I was contesting. In addition to this it is well known now that for men under 40 the risk of myocarditis from the vaccine outweighs the risk from the virus: https://vinayprasadmdmph.substack.com/p/uk-now-reports-myoca... https://www.nature.com/articles/s41591-021-01630-0.pdf |
|
“We esti- mated an extra two (95% confidence interval (CI) 0, 3), one (95% CI 0, 2) and six (95% CI 2, 8) myocarditis events per 1 million people vaccinated with ChAdOx1, BNT162b2 and mRNA-1273, respectively, in the 28 days following a first dose and an extra ten (95% CI 7, 11) myocarditis events per 1 million vaccinated in the 28 days after a second dose of mRNA-1273. This compares with an extra 40 (95% CI 38, 41) myocarditis events per 1 million patients in the 28 days following a SARS-CoV-2 positive test.”
Vaccine = +2-10 myocarditis events
COVID infection = +40 myocarditis events
And…
“the increased risk of myocarditis associated with the two mRNA vaccines was present only in those younger than 40.”
I don’t see how you justify saying that the vaccine risk outweighs the risk form infection. That increase in myocarditis from vaccines was only present in men under 40 but the increase was still less than the increase from the virus.